Regentis Biomaterials Ltd. Retained Earnings
Regentis Biomaterials Ltd. (RGNT) had Retained Earnings of -$55.79 million as of 2025-12-31, per its 20-F/A filed 2026-02-27.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-02-27
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$55.79M.
- 2024-12-31: Retained Earnings (Accumulated Deficit) -$42.15M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2025-12-31 | -$55.79M 20-F/A · filed 2026-02-27 |
| 2024-12-31 | -$42.15M 20-F/A · filed 2026-02-27 |